The Division of Liver Diseases is distinguished by its leadership in hepatic fibrosis, hepatocellular carcinoma, hepatitis C virus infection, primary biliary cirrhosis, and liver immunology.

Over the past decade, there has been an upswing in chronic liver disease, a growing incidence of liver cancer, and an ever-increasing shortage of organs available for liver transplantation. Basic, translational, and clinical research projects, as well as patient care initiatives within the Division are geared toward finding solutions for each of these concerns.